← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:476 | 476 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:476 | 476 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2208 | 72627-2208-9 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-053 | 70713-053-01 | Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-020 | 69761-020-01 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:476 | 476 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:476 | 476 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5010 | 71266-5010-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:476 | 476 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:476 | 476 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4607 | 72934-4607-8 | Finasteride; Tretinoin; Minoxidil | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4520 | 72682-4520-1 | Glutathione | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:476 | 476 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:477 | 477 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1229 | 73271-1229-1 | TESTOSTERONE CYPIONATE/PROPIONATE 200 MG/10 MG/ML MIGLYOL 812N | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:477 | 477 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:477 | 477 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:477 | 477 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2209 | 72627-2209-9 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-022 | 69761-022-01 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:477 | 477 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:477 | 477 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5040 | 71266-5040-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-5 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:477 | 477 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4352 | 72934-4352-8 | Finasteride; Minoxidil | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2630 | 72934-2630-2 | Fluorouracil; Calcipotriene | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5028 | 26436-5028-3 | Glutathione | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:477 | 477 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:478 | 478 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-160 | 70092-160-37 | Fent 2 mcg/ml-Bup 0.1% PF 250 ml NS IVB | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:478 | 478 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:478 | 478 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:478 | 478 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:478 | 478 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-025 | 69761-025-01 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:478 | 478 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5005 | 71266-5005-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9227 | 71266-9227-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4345 | 72934-4345-8 | Finasteride; Minoxidil | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-135 | 69194-135-01 | Foscarnet Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:478 | 478 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:478 | 478 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-15 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:479 | 479 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0009 | 71285-0009-1 | Reperfusate 4 to 1 Low K (15 mEq) Low Tromethamine 500ml Bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:479 | 479 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:479 | 479 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:479 | 479 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2010 | 70168-2010-1 | Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:479 | 479 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-104 | 70092-104-36 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:479 | 479 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:479 | 479 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:479 | 479 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4353 | 72934-4353-8 | Finasteride; Tretinoin; Minoxidil | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-157 | 73177-157-01 | Furosemide | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:479 | 479 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:480 | 480 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1040 | 73013-1040-1 | Hydromorphone HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:480 | 480 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:480 | 480 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2020 | 70168-2020-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:480 | 480 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-255 | 70092-255-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:480 | 480 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:480 | 480 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:480 | 480 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:480 | 480 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Foscarnet Sodium | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6440 | 71300-6440-2 | Gabapentin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:480 | 480 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-3 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:481 | 481 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:481 | 481 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:481 | 481 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:481 | 481 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:481 | 481 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-100 | 63037-100-05 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:481 | 481 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-157 | 73177-157-03 | Furosemide | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:481 | 481 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0428 | 71285-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Aspartic Acid; Leucine; Methionine; Proline; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:481 | 481 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gonadorelin Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:482 | 482 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0203 | 71285-0203-1 | Modified St. Thomas Low K (62 mEq) High Sodium Bicarbonate 1000 mL Bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:482 | 482 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:482 | 482 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:482 | 482 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:482 | 482 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-202 | 70092-202-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-092 | 70092-092-36 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:482 | 482 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-157 | 73177-157-01 | Furosemide | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:482 | 482 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0404 | 71285-0404-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:482 | 482 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:482 | 482 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gonadorelin Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:483 | 483 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-9 | Glycopyrrolate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:483 | 483 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:483 | 483 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9150 | 51754-9150-1 | Fentanyl Citrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5343 | 26436-5343-1 | Estriol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:483 | 483 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:483 | 483 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-500 | 70092-500-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-093 | 70092-093-37 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:483 | 483 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6630 | 71300-6630-2 | Gabapentin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:483 | 483 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0413 | 72196-0413-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:483 | 483 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:483 | 483 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gonadorelin Acetate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:484 | 484 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5457 | 26436-5457-1 | TESTOSTERONE 25mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:484 | 484 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:484 | 484 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:484 | 484 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5342 | 26436-5342-1 | Estriol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:484 | 484 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:484 | 484 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-400 | 70092-400-43 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:484 | 484 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6440 | 71300-6440-2 | Gabapentin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0419 | 72196-0419-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:484 | 484 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:484 | 484 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:485 | 485 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0061 | 81483-0061-0 | Lorazepam 2mg/mL. 1mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:485 | 485 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide; Hydroquinone; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:485 | 485 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:485 | 485 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5228 | 26436-5228-3 | Estriol; Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:485 | 485 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:485 | 485 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0428 | 71285-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Aspartic Acid; Leucine; Methionine; Proline; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0420 | 71285-0420-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4587 | 72682-4587-1 | Glutathione | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:485 | 485 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-216 | 70092-216-50 | Heparin Sodium | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:486 | 486 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | ESTRADIOL 18MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:486 | 486 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide; Hydroquinone; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:486 | 486 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:486 | 486 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Felis Catus Skin; Felis Catus Dander | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:486 | 486 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-441 | 70092-441-76 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1019 | 73013-1019-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0404 | 71285-0404-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:486 | 486 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0420 | 72196-0420-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:486 | 486 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione; Ascorbic Acid; Zinc Sulfate Heptahydrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:486 | 486 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:487 | 487 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-9 | Lidocaine HCl 2% | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:487 | 487 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide; Ketoconazole | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:487 | 487 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:487 | 487 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:487 | 487 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-108 | 70092-108-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0405 | 72196-0405-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0428 | 72196-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:487 | 487 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:487 | 487 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-217 | 70092-217-47 | Heparin Sodium | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:488 | 488 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | ESTRADIOL 18 PEL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:488 | 488 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Desonide; Minoxidil; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:488 | 488 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2010 | 70168-2010-1 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:488 | 488 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:488 | 488 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-25 | Fentanyl | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:488 | 488 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2020 | 70168-2020-1 | Estradiol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:488 | 488 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-371 | 73693-371-01 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:488 | 488 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-225 | 70092-225-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:488 | 488 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-254 | 70004-254-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 |